|Articles|February 5, 2008
FDA approves reduced-dose pediatric asthma inhaler
The Food and Drug Administration approved Schering-Plough's Asmanex Twisthaler (mometasone furoate inhalation powder) in a 110-mcg formulation, for preventative asthma therapy for children 4 to 11 years of age....
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Chronicity, Symptom Variability, and Treatment Expectations in Pediatric Functional Constipation and IBS-C
2
Weekly review: Formula recall, FDA warning for bassinet, and more
3
Empowering underserved children through representation, health literacy, and trusted content
4
FDA clears Capvaxive as supplemental PCV for at-risk children
5